{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:34:19Z","timestamp":1780472059206,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s10067-005-0070-8","type":"journal-article","created":{"date-parts":[[2005,10,31]],"date-time":"2005-10-31T15:02:42Z","timestamp":1130770962000},"page":"482-486","source":"Crossref","is-referenced-by-count":94,"title":["CNS involvement occurs more frequently in patients with Beh\u00e7et's disease under cyclosporin A (CSA) than under other medications\u2014results of a retrospective analysis of 117 cases"],"prefix":"10.1007","volume":"25","author":[{"given":"Ina","family":"K\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"G\u00fcnaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Vonthein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"St\u00fcbiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fierlbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Melms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"70_CR1","first-page":"1078","volume":"335","author":"International Study Group for Behcet's Disease","year":"1990","unstructured":"International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"issue":"(Pt 11)","key":"70_CR2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behcet's syndrome. Brain 122(Pt 11):2183\u20132194","journal-title":"Brain"},{"issue":"(Pt 11)","key":"70_CR3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122(Pt 11):2171\u20132182","journal-title":"Brain"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S, et al (2001) Behcet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95\u2013103","journal-title":"J Neurol"},{"key":"70_CR5","first-page":"177","volume-title":"Recent advances in Beh\u00e7et's disease","author":"N Dilsen","year":"1985","unstructured":"Dilsen N, Konice M, Aral O (1985) Our diagnostic criteria of Behcet's disease\u2014an overview. In: Lehner T, Barnes CG (eds) Recent advances in Beh\u00e7et's disease. Royal Society of Medicine Services, London, pp 177\u2013180"},{"key":"70_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0714.1999.tb02023.x","volume":"28","author":"I Krause","year":"1999","unstructured":"Krause I, Rosen Y, Kaplan I, et al (1999) Recurrent aphthous stomatitis in Behcet's disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med 28:193\u2013196","journal-title":"J Oral Pathol Med"},{"key":"70_CR7","first-page":"133","volume":"31","author":"I Kotter","year":"2004","unstructured":"Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133\u2013139","journal-title":"J Rheumatol"},{"key":"70_CR8","unstructured":"Saenz A, Ausejo M, Shea B, Wells G, Welch V, Tugwell P (2000) Pharmacotherapy for Behcet's syndrome. Cochrane Database Syst Rev 2:CD001084"},{"key":"70_CR9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494\u2013500","journal-title":"N Engl J Med"},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s004150050360","volume":"246","author":"JMM Gijtenbeek","year":"1999","unstructured":"Gijtenbeek JMM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339\u2013346","journal-title":"J Neurol"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJM200108093450606","volume":"345","author":"CM Filley","year":"2001","unstructured":"Filley CM, Kleinschmidt-DeMasters BK (2001) Toxic leukoencephalopathy. N Engl J Med 345:425\u2013432","journal-title":"N Engl J Med"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/crad.2000.0675","volume":"56","author":"SH Lee","year":"2001","unstructured":"Lee SH, Yoon PH, Park SJ, Kim DI (2001) MRI findings in neuro-Beh\u00e7et's disease. Clin Radiol 56:485\u2013494","journal-title":"Clin Radiol"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1442-9071.2001.00445.x","volume":"29","author":"Y Kato","year":"2001","unstructured":"Kato Y, Numaga J, Kato S, Kaburaki T, Kawashima H, Fujino Y (2001) Central nervous system symptoms in a population of Behcet's disease patients with refractory uveitis treated with cyclosporine A. Clin Experiment Ophthalmol 29:335\u2013336","journal-title":"Clin Experiment Ophthalmol"},{"key":"70_CR14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","volume":"106","author":"S Kotake","year":"1999","unstructured":"Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H (1999) Central nervous system symptoms in patients with Behcet disease receiving cyclosporine therapy. Ophthalmology 106:586\u2013589","journal-title":"Ophthalmology"},{"key":"70_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s003930050018","volume":"56","author":"S Meusser","year":"1997","unstructured":"Meusser S, Eger G, Anders M, Burkhardt H, Kalden JR (1997) Manifestation of neuro-Behcet disease in cyclosporin A therapy. Z Rheumatol 56:31\u201339","journal-title":"Z Rheumatol"},{"key":"70_CR16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s004150200031","volume":"249","author":"A Lannuzel","year":"2002","unstructured":"Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behcet's disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410\u2013418","journal-title":"J Neurol"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004150050205","volume":"245","author":"P Serdaroglu","year":"1998","unstructured":"Serdaroglu P (1998) Behcet's disease and the nervous system. J Neurol 245:197\u2013205","journal-title":"J Neurol"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","volume":"58","author":"BN McLean","year":"1995","unstructured":"McLean BN, Miller D, Thompson EJ (1995) Oligoclonal banding of IgG in CSF, blood\u2013brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 58:548\u2013554","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"70_CR19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/jnnp.43.3.210","volume":"43","author":"S Motomura","year":"1980","unstructured":"Motomura S, Tabira T, Kuroiwa Y (1980) A clinical comparative study of multiple sclerosis and neuro-Behcet's syndrome. J Neurol Neurosurg Psychiatry 43:210\u2013213","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"70_CR20","first-page":"347","volume":"17","author":"I Krause","year":"1999","unstructured":"Krause I, Leibovici L, Guedj D, Molad Y, Uziel Y, Weinberger A (1999) Disease patterns of patients with Behcet's disease demonstrated by factor analysis. Clin Exp Rheumatol 17:347\u2013350","journal-title":"Clin Exp Rheumatol"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","volume":"44","author":"S Yurdakul","year":"2001","unstructured":"Yurdakul S, Mat C, Tuzun Y, et al (2001) A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum 44:2686\u20132692","journal-title":"Arthritis Rheum"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","volume":"128","author":"V Hamuryudan","year":"1998","unstructured":"Hamuryudan V, Mat C, Saip S, et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443\u2013450","journal-title":"Ann Intern Med"},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","volume":"33","author":"I Kotter","year":"2004","unstructured":"Kotter I, Vonthein R, Zierhut M, et al (2004) Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behcet disease: results of an open 4-center trial. Semin Arthritis Rheum 33:311\u2013319","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0070-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-0070-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0070-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:50:51Z","timestamp":1559119851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-0070-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-0070-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,1]]}}}